Executive leaders from FCS discuss industry-leading approach to value-based care at AVBCC Summit 2023

Fort Myers, Fla., October 18, 2023 – Executive leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2023 Summit & Educational Program in New York, NY on Oct. 18 – 20. During the invitation-only forum, they will join leading physicians, policymakers, pharmacists and payers from across the country to share insights and best practice strategies that focus on clinical, cost and access issues designed to maximize value in cancer care.

Participating on the diverse panel of influential stakeholders are:

• Lucio N. Gordan, MD, FCS President & Managing Physician – Integrating Precision Medicine Data into Real-World Pathways and Clinical Utility
• Nathan H. Walcker, FCS Chief Executive officer – Building the Conglomerates of Oncology Practice: Consolidation, Competition, and Care, and The Ever-Changing Relationships Between Regional and Community in Cancer Care
• Josh Eaves, FCS Chief Development & Strategy Officer – Value-Based Agreements in Oncology: What Cancer Practice are Doing in the Marketplace Today and Innovative Reimbursement Models Based on Outcomes and Services
• Kiana Mehring, FCS Senior Director of Strategic Partnerships, Managed Care – Innovative Reimbursement Models Based on Outcomes and Services

“We welcome every opportunity to engage in forums such as the AVBCC Summit, so that we can share and learn and build upon our impressive track record of maximizing quality and value in community oncology care,” said FCS Chief Executive Officer Nathan H. Walcker.

Dr. Lucio Gordan added, “We remain steadfast in our commitment to ensuring that cancer patients receive optimal care at every step of their journey. By sharing our experiences and perspectives, especially as it relates to emerging opportunities in in the field of real-world data research, we will continue to find meaningful solutions to advance the many facets of value-based cancer care.”

FCS is a leader in the value-based oncology care space, pioneering several tactics throughout the statewide practice inclusive of integrating biosimilar drugs, constructing care coordination services, and utilizing genomic testing to improve the quality of care delivered to patients.